208 related articles for article (PubMed ID: 1411279)
1. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
[TBL] [Abstract][Full Text] [Related]
2. Effects of endogenous and exogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth.
Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF; Sundler F
Scand J Gastroenterol; 1990 May; 25(5):471-80. PubMed ID: 2359975
[TBL] [Abstract][Full Text] [Related]
3. Portacaval shunt increases the trophic effect of cholecystokinin on the rat pancreas.
Nylander AG; Chen D; Rehfeld JF; Håkanson R
Scand J Gastroenterol; 1993 Feb; 28(2):145-8. PubMed ID: 8441908
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in rats.
Gasslander T; Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF
Scand J Gastroenterol; 1990 Oct; 25(10):1060-5. PubMed ID: 2263879
[TBL] [Abstract][Full Text] [Related]
5. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.
Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I
Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866
[TBL] [Abstract][Full Text] [Related]
6. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
[TBL] [Abstract][Full Text] [Related]
7. Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.
Ohlsson B; Axelson J; Sternby B; Rehfeld JF; Ihse I
Int J Pancreatol; 1995 Aug; 18(1):59-66. PubMed ID: 7594771
[TBL] [Abstract][Full Text] [Related]
8. Effects of a cholecystokinin receptor antagonist on rat exocrine pancreatic response to raw soya flour.
Sundaram S; Dayan AD
Hum Exp Toxicol; 1991 May; 10(3):179-82. PubMed ID: 1678946
[TBL] [Abstract][Full Text] [Related]
9. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R
Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
[TBL] [Abstract][Full Text] [Related]
10. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.
Ohlsson B; Borg K; Rehfeld JF; Ihse I; Axelson J
Int J Pancreatol; 1998 Dec; 24(3):211-8. PubMed ID: 9873956
[TBL] [Abstract][Full Text] [Related]
11. Dose-related involvement of CCK in bombesin-induced pancreatic growth.
Liehr RM; Reidelberger RD; Rosewicz S; Bussjaeger LJ; Solomon TE
Regul Pept; 1992 Apr; 38(3):207-19. PubMed ID: 1375383
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H
Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
[TBL] [Abstract][Full Text] [Related]
13. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
Zucker KA; Adrian TE; Bilchik AJ; Modlin IM
Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
[TBL] [Abstract][Full Text] [Related]
14. Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas.
Ohlsson B; Borg K; Mulder H; Rehfeld JF; Axelson J; Sundler F
Scand J Gastroenterol; 2000 Jun; 35(6):612-8. PubMed ID: 10912661
[TBL] [Abstract][Full Text] [Related]
15. The ratio between anionic and cationic trypsin in rat pancreas varies with CCK stimulation.
Borgström A; Axelson J; Ihse I; Rehfeld JF
Pancreas; 1995 Aug; 11(2):179-84. PubMed ID: 7479676
[TBL] [Abstract][Full Text] [Related]
16. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
[TBL] [Abstract][Full Text] [Related]
17. Chronic administration of a potent cholecystokinin receptor antagonist, L-364,718, fails to inhibit pancreas growth in preweanling rats.
Wisner JR; Ozawa S; Xue BG; Renner IG
Pancreas; 1990 Jul; 5(4):434-8. PubMed ID: 1696382
[TBL] [Abstract][Full Text] [Related]
18. Endogenous cholecystokinin, the major factor responsible for dietary protein-induced pancreatic growth.
Morisset J; Guan D; Jurkowska G; Rivard N; Green GM
Pancreas; 1992; 7(5):522-9. PubMed ID: 1381095
[TBL] [Abstract][Full Text] [Related]
19. Effects of peptide YY on CCK/CCK antagonist interactions in cerulein-induced pancreatic injury.
Tito JM; Rudnicki M; Robinson DC; Guiney WB; Adrian TE; Gold MS
Ann N Y Acad Sci; 1995 May; 757():410-2. PubMed ID: 7541974
[No Abstract] [Full Text] [Related]
20. Effects of high fat diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster.
Herrington MK; Permert J; Kazakoff KR; Pour PM; Zuker KA; Bilchik AJ; Adrian TE
Carcinogenesis; 1993 May; 14(5):1021-6. PubMed ID: 7684953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
